Proteomic analysis shows synthetic oleanane triterpenoid binds to mTOR
about
Ursolic acid increases skeletal muscle and brown fat and decreases diet-induced obesity, glucose intolerance and fatty liver diseaseHost gene targets for novel influenza therapies elucidated by high-throughput RNA interference screensThe clinical potential of influencing Nrf2 signaling in degenerative and immunological disordersReactive oxygen species in inflammation and tissue injuryInhibition of transglutaminase 2, a novel target for pulmonary fibrosis, by two small electrophilic molecules.Synthetic triterpenoid induces 15-PGDH expression and suppresses inflammation-driven colon carcinogenesis.Induction of heme oxygenase I (HMOX1) by HPP-4382: a novel modulator of Bach1 activity.NRF2 and cancer: the good, the bad and the importance of context.Bardoxolone methyl (CDDO-Me) as a therapeutic agent: an update on its pharmacokinetic and pharmacodynamic properties.CDDO-methyl ester delays breast cancer development in BRCA1-mutated mice.Pharmacological induction of heme oxygenase-1 by a triterpenoid protects neurons against ischemic injury.Emerging PPARγ-Independent Role of PPARγ Ligands in Lung Diseases.Probing the structural requirements of non-electrophilic naphthalene-based Nrf2 activators.Non-electrophilic modulators of the canonical Keap1/Nrf2 pathwaySynthetic oleanane triterpenoids: multifunctional drugs with a broad range of applications for prevention and treatment of chronic disease.Transcriptomic and proteomic insight into the effects of a defined European mistletoe extract in Ewing sarcoma cells reveals cellular stress responses.Stress granules and RNA processing bodies are novel autoantibody targets in systemic sclerosis.Prevention of murine lupus nephritis by targeting multiple signaling axes and oxidative stress using a synthetic triterpenoid.Natural compound-derived epigenetic regulators targeting epigenetic readers, writers and erasers.The Nrf2 triterpenoid activator, CDDO-imidazolide, protects kidneys from ischemia-reperfusion injury in mice.Differential regulation of innate immune cytokine production through pharmacological activation of Nuclear Factor-Erythroid-2-Related Factor 2 (NRF2) in burn patient immune cells and monocytes.CDDO and ATRA Instigate Differentiation of IMR32 Human Neuroblastoma Cells.Bardoxolone brings Nrf2-based therapies to light.Dimethyl fumarate inhibits osteoclasts via attenuation of reactive oxygen species signalling by augmented antioxidation.A bifurcated signaling cascade of NIMA-related kinases controls distinct kinesins in anaphase.C151 in KEAP1 is the main cysteine sensor for the cyanoenone class of NRF2 activators, irrespective of molecular size or shape.Synthesis and Biological Evaluation of New Madecassic Acid Derivatives Targeting ERK Cascade Signaling
P2860
Q21134517-48784F24-A247-4012-886A-C146277DBB20Q26852062-3656AD0D-3B53-49ED-BF32-91E7C7121680Q28395641-8960C410-5CB3-4DF1-8C72-25903C48E4ACQ28396273-92096BD3-7B85-4F0F-AA5F-76ADF0604DB8Q33799573-B07854FD-6DCA-471A-A33E-90B46D53AD19Q33872540-F024339C-3CDB-4E45-8D14-9846199F58F9Q33895178-B392F623-F4B2-467E-962A-C8EB4B367267Q34289003-389F47BD-7E96-4387-B5D6-0C9D162B27A6Q34415403-1B6B36B1-17B3-4E2C-9ECB-66B0CCAD0D86Q35656210-B9C7CD22-DF55-4154-9237-7BEDFBB03B20Q35911185-4E158082-5BEC-4B1A-A635-D5515735E8E4Q36063833-7E1EB4F0-F2B5-48DE-A1A4-CCC13E500A12Q36144939-1722AE92-88B4-47AC-BE63-9C7DDAADBAC7Q36277241-8176586F-3A69-4630-8983-A8C75EF8B551Q36293645-96A1D77E-B85B-4394-AA97-B13220F58D02Q36358448-07E1D555-7BF4-4278-BA84-039AF8B0480AQ36493693-AB450D85-7F28-4ED7-A972-1C5CA9F759F4Q36823420-9C4FEED9-B01A-4754-8B30-92F610BACBFDQ37114055-EA4204B4-23DC-4282-86FB-F7DB0907A3EFQ37616058-75D7772D-7956-4EA5-BC9D-E1F3C1CE8465Q40060254-FC176F1E-B066-4455-9607-626230D943E4Q42227825-F04FC210-9AA5-4FBF-8582-EAA134B56975Q43102933-F1BC5284-B35A-4B60-9361-DC0E78267312Q46276290-06966516-F467-4D9D-A401-6784A37D12E2Q48255762-2D09567C-C4DB-407A-9D9B-C3A5E836C1D5Q55256229-462C63DD-2B67-4394-AA6F-C97960DA9B5AQ57490053-E58EB0D0-9DEC-4ACC-ADAB-15D0BEAD5D4B
P2860
Proteomic analysis shows synthetic oleanane triterpenoid binds to mTOR
description
2011 nî lūn-bûn
@nan
2011 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Proteomic analysis shows synthetic oleanane triterpenoid binds to mTOR
@ast
Proteomic analysis shows synthetic oleanane triterpenoid binds to mTOR
@en
type
label
Proteomic analysis shows synthetic oleanane triterpenoid binds to mTOR
@ast
Proteomic analysis shows synthetic oleanane triterpenoid binds to mTOR
@en
prefLabel
Proteomic analysis shows synthetic oleanane triterpenoid binds to mTOR
@ast
Proteomic analysis shows synthetic oleanane triterpenoid binds to mTOR
@en
P2860
P50
P1433
P1476
Proteomic analysis shows synthetic oleanane triterpenoid binds to mTOR
@en
P2093
Mark M Yore
Michael B Sporn
P2860
P304
P356
10.1371/JOURNAL.PONE.0022862
P407
P577
2011-07-27T00:00:00Z